▶ 調査レポート

コネクテッド注射用ドラッグデリバリーデバイスの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Connected Injectable Drug Delivery Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。コネクテッド注射用ドラッグデリバリーデバイスの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Connected Injectable Drug Delivery Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-04426資料のイメージです。• レポートコード:D005-04426
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、131ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
  Corporate User¥723,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、コネクテッド注射用ドラッグデリバリーデバイスの世界市場を広く調査・分析し、今後の市場展望をまとめております。コネクテッド注射用ドラッグデリバリーデバイスの種類別市場規模(従来、自己注射、その他)、用途別市場規模(糖尿病、心血管疾患、自己免疫疾患、ホルモン補充、神経学、中毒、呼吸器疾患、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Phillips-Medisize、SHL、Aterica、West Pharmaceutical Services、Haselmeier、Biocorp、Baxter International、Propeller Health、Unilife、Becton Dickinson、Owen Mumford、Scandinavian Health、Antares Pharma、Schott、Ypsomed、Zogenix、Terumo Medical
・地域別グローバル市場分析 2015年-2020年
・コネクテッド注射用ドラッグデリバリーデバイスの北米市場(アメリカ、カナダ、メキシコ)
・コネクテッド注射用ドラッグデリバリーデバイスのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・コネクテッド注射用ドラッグデリバリーデバイスのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・コネクテッド注射用ドラッグデリバリーデバイスの南米市場(ブラジル、アルゼンチン)
・コネクテッド注射用ドラッグデリバリーデバイスの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:従来、自己注射、その他
・用途別分析:糖尿病、心血管疾患、自己免疫疾患、ホルモン補充、神経学、中毒、呼吸器疾患、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Connected Injectable Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Connected Injectable Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Connected Injectable Drug Delivery Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Connected Injectable Drug Delivery Devices market has been segmented into
Conventional
Self-Injection
Others

By Application, Connected Injectable Drug Delivery Devices has been segmented into:
Diabetes
Cardiovascular Diseases
Autoimmune Diseases
Hormones Replacement
Neurology
Addiction
Respiratory Diseases
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Connected Injectable Drug Delivery Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Connected Injectable Drug Delivery Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Connected Injectable Drug Delivery Devices market.

The report offers in-depth assessment of the growth and other aspects of the Connected Injectable Drug Delivery Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Connected Injectable Drug Delivery Devices Market Share Analysis
Connected Injectable Drug Delivery Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Connected Injectable Drug Delivery Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Connected Injectable Drug Delivery Devices sales, revenue and market share for each player covered in this report.

The major players covered in Connected Injectable Drug Delivery Devices are:
Phillips-Medisize
SHL
Aterica
West Pharmaceutical Services
Haselmeier
Biocorp
Baxter International
Propeller Health
Unilife
Becton Dickinson
Owen Mumford
Scandinavian Health
Antares Pharma
Schott
Ypsomed
Zogenix
Terumo Medical

Among other players domestic and global, Connected Injectable Drug Delivery Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Connected Injectable Drug Delivery Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Connected Injectable Drug Delivery Devices, with price, sales, revenue and global market share of Connected Injectable Drug Delivery Devices in 2018 and 2019.
Chapter 3, the Connected Injectable Drug Delivery Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Connected Injectable Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Connected Injectable Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Connected Injectable Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Connected Injectable Drug Delivery Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Connected Injectable Drug Delivery Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Conventional
1.2.3 Self-Injection
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Connected Injectable Drug Delivery Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Cardiovascular Diseases
1.3.4 Autoimmune Diseases
1.3.5 Hormones Replacement
1.3.6 Neurology
1.3.7 Addiction
1.3.8 Respiratory Diseases
1.3.9 Others
1.4 Overview of Global Connected Injectable Drug Delivery Devices Market
1.4.1 Global Connected Injectable Drug Delivery Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Phillips-Medisize
2.1.1 Phillips-Medisize Details
2.1.2 Phillips-Medisize Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Phillips-Medisize SWOT Analysis
2.1.4 Phillips-Medisize Product and Services
2.1.5 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 SHL
2.2.1 SHL Details
2.2.2 SHL Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SHL SWOT Analysis
2.2.4 SHL Product and Services
2.2.5 SHL Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aterica
2.3.1 Aterica Details
2.3.2 Aterica Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aterica SWOT Analysis
2.3.4 Aterica Product and Services
2.3.5 Aterica Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 West Pharmaceutical Services
2.4.1 West Pharmaceutical Services Details
2.4.2 West Pharmaceutical Services Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 West Pharmaceutical Services SWOT Analysis
2.4.4 West Pharmaceutical Services Product and Services
2.4.5 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Haselmeier
2.5.1 Haselmeier Details
2.5.2 Haselmeier Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Haselmeier SWOT Analysis
2.5.4 Haselmeier Product and Services
2.5.5 Haselmeier Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biocorp
2.6.1 Biocorp Details
2.6.2 Biocorp Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biocorp SWOT Analysis
2.6.4 Biocorp Product and Services
2.6.5 Biocorp Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Baxter International
2.7.1 Baxter International Details
2.7.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Baxter International SWOT Analysis
2.7.4 Baxter International Product and Services
2.7.5 Baxter International Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Propeller Health
2.8.1 Propeller Health Details
2.8.2 Propeller Health Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Propeller Health SWOT Analysis
2.8.4 Propeller Health Product and Services
2.8.5 Propeller Health Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Unilife
2.9.1 Unilife Details
2.9.2 Unilife Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Unilife SWOT Analysis
2.9.4 Unilife Product and Services
2.9.5 Unilife Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Becton Dickinson
2.10.1 Becton Dickinson Details
2.10.2 Becton Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Becton Dickinson SWOT Analysis
2.10.4 Becton Dickinson Product and Services
2.10.5 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Owen Mumford
2.11.1 Owen Mumford Details
2.11.2 Owen Mumford Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Owen Mumford SWOT Analysis
2.11.4 Owen Mumford Product and Services
2.11.5 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Scandinavian Health
2.12.1 Scandinavian Health Details
2.12.2 Scandinavian Health Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Scandinavian Health SWOT Analysis
2.12.4 Scandinavian Health Product and Services
2.12.5 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Antares Pharma
2.13.1 Antares Pharma Details
2.13.2 Antares Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Antares Pharma SWOT Analysis
2.13.4 Antares Pharma Product and Services
2.13.5 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Schott
2.14.1 Schott Details
2.14.2 Schott Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Schott SWOT Analysis
2.14.4 Schott Product and Services
2.14.5 Schott Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ypsomed
2.15.1 Ypsomed Details
2.15.2 Ypsomed Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Ypsomed SWOT Analysis
2.15.4 Ypsomed Product and Services
2.15.5 Ypsomed Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Zogenix
2.16.1 Zogenix Details
2.16.2 Zogenix Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Zogenix SWOT Analysis
2.16.4 Zogenix Product and Services
2.16.5 Zogenix Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Terumo Medical
2.17.1 Terumo Medical Details
2.17.2 Terumo Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Terumo Medical SWOT Analysis
2.17.4 Terumo Medical Product and Services
2.17.5 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Connected Injectable Drug Delivery Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Connected Injectable Drug Delivery Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Connected Injectable Drug Delivery Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Connected Injectable Drug Delivery Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.3 Europe Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.5 South America Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Country
5.1.1 North America Connected Injectable Drug Delivery Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Connected Injectable Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
5.3 Canada Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Connected Injectable Drug Delivery Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Connected Injectable Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.3 UK Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.4 France Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.5 Russia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.6 Italy Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Connected Injectable Drug Delivery Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Connected Injectable Drug Delivery Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.3 Japan Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.4 Korea Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.5 India Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.7 Australia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Country
8.1.1 South America Connected Injectable Drug Delivery Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Connected Injectable Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Connected Injectable Drug Delivery Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Connected Injectable Drug Delivery Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Connected Injectable Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Connected Injectable Drug Delivery Devices Sales and Market Share by Type (2015-2020)
10.2 Global Connected Injectable Drug Delivery Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Connected Injectable Drug Delivery Devices Price by Type (2015-2020)
11 Global Connected Injectable Drug Delivery Devices Market Segment by Application
11.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2015-2020)
11.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2015-2020)
11.3 Global Connected Injectable Drug Delivery Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Connected Injectable Drug Delivery Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Connected Injectable Drug Delivery Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Connected Injectable Drug Delivery Devices Market Forecast (2021-2025)
12.2.2 Europe Connected Injectable Drug Delivery Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Connected Injectable Drug Delivery Devices Market Forecast (2021-2025)
12.2.4 South America Connected Injectable Drug Delivery Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Connected Injectable Drug Delivery Devices Market Forecast (2021-2025)
12.3 Connected Injectable Drug Delivery Devices Market Forecast by Type (2021-2025)
12.3.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Connected Injectable Drug Delivery Devices Market Share Forecast by Type (2021-2025)
12.4 Connected Injectable Drug Delivery Devices Market Forecast by Application (2021-2025)
12.4.1 Global Connected Injectable Drug Delivery Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Connected Injectable Drug Delivery Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Connected Injectable Drug Delivery Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Connected Injectable Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Connected Injectable Drug Delivery Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Phillips-Medisize Basic Information, Manufacturing Base and Competitors
Table 8. Phillips-Medisize Connected Injectable Drug Delivery Devices Major Business
Table 9. Phillips-Medisize Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 10. Phillips-Medisize SWOT Analysis
Table 11. Phillips-Medisize Connected Injectable Drug Delivery Devices Product and Services
Table 12. Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. SHL Basic Information, Manufacturing Base and Competitors
Table 14. SHL Connected Injectable Drug Delivery Devices Major Business
Table 15. SHL Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 16. SHL SWOT Analysis
Table 17. SHL Connected Injectable Drug Delivery Devices Product and Services
Table 18. SHL Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Aterica Basic Information, Manufacturing Base and Competitors
Table 20. Aterica Connected Injectable Drug Delivery Devices Major Business
Table 21. Aterica Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 22. Aterica SWOT Analysis
Table 23. Aterica Connected Injectable Drug Delivery Devices Product and Services
Table 24. Aterica Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 26. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Major Business
Table 27. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 28. West Pharmaceutical Services SWOT Analysis
Table 29. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product and Services
Table 30. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 32. Haselmeier Connected Injectable Drug Delivery Devices Major Business
Table 33. Haselmeier Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 34. Haselmeier SWOT Analysis
Table 35. Haselmeier Connected Injectable Drug Delivery Devices Product and Services
Table 36. Haselmeier Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biocorp Basic Information, Manufacturing Base and Competitors
Table 38. Biocorp Connected Injectable Drug Delivery Devices Major Business
Table 39. Biocorp Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 40. Biocorp SWOT Analysis
Table 41. Biocorp Connected Injectable Drug Delivery Devices Product and Services
Table 42. Biocorp Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Baxter International Basic Information, Manufacturing Base and Competitors
Table 44. Baxter International Connected Injectable Drug Delivery Devices Major Business
Table 45. Baxter International Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 46. Baxter International SWOT Analysis
Table 47. Baxter International Connected Injectable Drug Delivery Devices Product and Services
Table 48. Baxter International Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Propeller Health Basic Information, Manufacturing Base and Competitors
Table 50. Propeller Health Connected Injectable Drug Delivery Devices Major Business
Table 51. Propeller Health Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 52. Propeller Health SWOT Analysis
Table 53. Propeller Health Connected Injectable Drug Delivery Devices Product and Services
Table 54. Propeller Health Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Unilife Basic Information, Manufacturing Base and Competitors
Table 56. Unilife Connected Injectable Drug Delivery Devices Major Business
Table 57. Unilife Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 58. Unilife SWOT Analysis
Table 59. Unilife Connected Injectable Drug Delivery Devices Product and Services
Table 60. Unilife Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 62. Becton Dickinson Connected Injectable Drug Delivery Devices Major Business
Table 63. Becton Dickinson Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 64. Becton Dickinson SWOT Analysis
Table 65. Becton Dickinson Connected Injectable Drug Delivery Devices Product and Services
Table 66. Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 68. Owen Mumford Connected Injectable Drug Delivery Devices Major Business
Table 69. Owen Mumford Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 70. Owen Mumford SWOT Analysis
Table 71. Owen Mumford Connected Injectable Drug Delivery Devices Product and Services
Table 72. Owen Mumford Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Scandinavian Health Basic Information, Manufacturing Base and Competitors
Table 74. Scandinavian Health Connected Injectable Drug Delivery Devices Major Business
Table 75. Scandinavian Health Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 76. Scandinavian Health SWOT Analysis
Table 77. Scandinavian Health Connected Injectable Drug Delivery Devices Product and Services
Table 78. Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Antares Pharma Connected Injectable Drug Delivery Devices Major Business
Table 81. Antares Pharma Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 82. Antares Pharma SWOT Analysis
Table 83. Antares Pharma Connected Injectable Drug Delivery Devices Product and Services
Table 84. Antares Pharma Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Schott Basic Information, Manufacturing Base and Competitors
Table 86. Schott Connected Injectable Drug Delivery Devices Major Business
Table 87. Schott Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 88. Schott SWOT Analysis
Table 89. Schott Connected Injectable Drug Delivery Devices Product and Services
Table 90. Schott Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 92. Ypsomed Connected Injectable Drug Delivery Devices Major Business
Table 93. Ypsomed Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 94. Ypsomed SWOT Analysis
Table 95. Ypsomed Connected Injectable Drug Delivery Devices Product and Services
Table 96. Ypsomed Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Zogenix Basic Information, Manufacturing Base and Competitors
Table 98. Zogenix Connected Injectable Drug Delivery Devices Major Business
Table 99. Zogenix Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 100. Zogenix SWOT Analysis
Table 101. Zogenix Connected Injectable Drug Delivery Devices Product and Services
Table 102. Zogenix Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 104. Terumo Medical Connected Injectable Drug Delivery Devices Major Business
Table 105. Terumo Medical Connected Injectable Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 106. Terumo Medical SWOT Analysis
Table 107. Terumo Medical Connected Injectable Drug Delivery Devices Product and Services
Table 108. Terumo Medical Connected Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Connected Injectable Drug Delivery Devices Sales by Manufacturer (2018-2019) (K Units)
Table 110. Global Connected Injectable Drug Delivery Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Connected Injectable Drug Delivery Devices Sales by Regions (2015-2020) (K Units)
Table 112. Global Connected Injectable Drug Delivery Devices Sales Market Share by Regions (2015-2020)
Table 113. Global Connected Injectable Drug Delivery Devices Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Connected Injectable Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 115. North America Connected Injectable Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 116. North America Connected Injectable Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Connected Injectable Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Table 118. Europe Connected Injectable Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 119. Europe Connected Injectable Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 120. Europe Connected Injectable Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Connected Injectable Drug Delivery Devices Sales by Regions (2015-2020) (K Units)
Table 122. Asia-Pacific Connected Injectable Drug Delivery Devices Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Connected Injectable Drug Delivery Devices Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Connected Injectable Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 125. South America Connected Injectable Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 126. South America Connected Injectable Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Connected Injectable Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Connected Injectable Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 129. Middle East & Africa Connected Injectable Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Connected Injectable Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Connected Injectable Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Table 132. Global Connected Injectable Drug Delivery Devices Sales by Type (2015-2020) (K Units)
Table 133. Global Connected Injectable Drug Delivery Devices Sales Share by Type (2015-2020)
Table 134. Global Connected Injectable Drug Delivery Devices Revenue by Type (2015-2020) (USD Million)
Table 135. Global Connected Injectable Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 136. Global Connected Injectable Drug Delivery Devices Sales by Application (2015-2020) (K Units)
Table 137. Global Connected Injectable Drug Delivery Devices Sales Share by Application (2015-2020)
Table 138. Global Connected Injectable Drug Delivery Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 139. Global Connected Injectable Drug Delivery Devices Market Share Forecast by Regions (2021-2025)
Table 140. Global Connected Injectable Drug Delivery Devices Sales Forecast by Type (2021-2025) (K Units)
Table 141. Global Connected Injectable Drug Delivery Devices Market Share Forecast by Type (2021-2025)
Table 142. Global Connected Injectable Drug Delivery Devices Sales Forecast by Application (2021-2025)
Table 143. Global Connected Injectable Drug Delivery Devices Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Connected Injectable Drug Delivery Devices Picture
Figure 2. Global Sales Market Share of Connected Injectable Drug Delivery Devices by Type in 2019
Figure 3. Conventional Picture
Figure 4. Self-Injection Picture
Figure 5. Others Picture
Figure 6. Connected Injectable Drug Delivery Devices Sales Market Share by Application in 2018
Figure 7. Diabetes Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Autoimmune Diseases Picture
Figure 10. Hormones Replacement Picture
Figure 11. Neurology Picture
Figure 12. Addiction Picture
Figure 13. Respiratory Diseases Picture
Figure 14. Others Picture
Figure 15. Global Connected Injectable Drug Delivery Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Connected Injectable Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturer in 2019
Figure 36. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Connected Injectable Drug Delivery Devices Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Connected Injectable Drug Delivery Devices Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
Figure 43. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Regions in 2018
Figure 44. North America Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 45. Europe Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 47. South America Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 49. North America Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Connected Injectable Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Figure 51. North America Connected Injectable Drug Delivery Devices Sales Market Share by Countries in 2018
Figure 52. North America Connected Injectable Drug Delivery Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Connected Injectable Drug Delivery Devices Revenue Market Share by Countries in 2018
Figure 54. United States Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Connected Injectable Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Connected Injectable Drug Delivery Devices Revenue Market Share by Countries in 2019
Figure 60. Germany Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Connected Injectable Drug Delivery Devices Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Connected Injectable Drug Delivery Devices Revenue Market Share by Regions 2019
Figure 68. China Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Connected Injectable Drug Delivery Devices Sales Market Share by Countries in 2019
Figure 75. South America Connected Injectable Drug Delivery Devices Revenue Market Share by Countries in 2019
Figure 76. Brazil Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Connected Injectable Drug Delivery Devices Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Connected Injectable Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Connected Injectable Drug Delivery Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Connected Injectable Drug Delivery Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Connected Injectable Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Connected Injectable Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Connected Injectable Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Connected Injectable Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Connected Injectable Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel